Improving lipid evaluation and management in medicare patients hospitalized for acute myocardial infarction

Archives of Internal Medicine

Volumn 161, Issue 6, 2001, Pages 839-844

  Malach, Monte ^a,b,c   Quinley, John ^a   Imperato, Pascal James ^a,c   Wallen, Marcia ^a  

^a IPRO Inc   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ARTICLE; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE COURSE; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY;

EID: 0035953114     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.6.839     Document Type: Article

References (30)

1. American College of Cardiology/American Heart Association (ACC/AHA) guidelines for the management of patients with acute myocardial infarction
2. ABC (aspirin, beta blocker, clot buster thrombolytic or PTCA) for day one of acute myocardial infarction in Medicare patients
3. Risk stratification after myocardial infarction
4. Do physicians follow NCEP guidelines?
5. Time trends in the use of cholesterollowering agents in older adults
6. Adherence to NCEP guidelines for patients with coronary heart disease
7. Cardiovascular risk factors in the elderly
8. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials
9. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
10. Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease
11. Changing seasonality of mortality from coronary heart disease
12. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperatire Cardiovascular Project
13. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992
14. The Lipid Treatment Assessment Project (L-TAP): A multi-center survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals
15. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada
16. Preventing coronary artery disease by lowering cholesterol levels
17. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS: Air Force/Texas Coronary Atherosclerosis Prevention Study
20. Baseline risk factors and their association with outcome on the West of Scotland Coronary Prevention Study
21. Clinical goals and performance measures for cholesterol management in secondary prevention Of coronary heart disease
22. Diabetes and cardiovascular disease: The Framingham Study
23. lc with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study
24. The evolving role of statins in the management of atherosclerosis
25. Vulnerable plaque: Pathology and clinical implications
26. Antiatherothrombotic properties of statins
27. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
28. Reductase inhibitor monotherapy and stroke prevention